tm
Seeing Is Believing
tm
Seeing Is Believing
Sonnet Biotherapeutics Holdings's activity chart (see below) currently has 2 price targets and 2 ratings on display.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 10 days.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 07-Apr-2025. First documented stock forecast 15-Sep-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Sep-2022
1 years 5 months 5 days ago
(07-Apr-2025)
1/1 (100%)
$65.12 (22.70%)
40
Buy Since 17-Dec-2021
3 years 20 days ago
(23-Aug-2023)
0/1 (0%)
$3769.92 (325.53%)
Buy Since 15-Sep-2021
$12142598
$12142597 (100000000.00%)
$30356496
4 years 7 months 3 days ago
(09-Feb-2022)
0/2 (0%)
$12141837 (1594714.50%)
What is SONN (Sonnet Biotherapeutics Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst has the most public recommendations on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst is the currently most bullish on SONN (Sonnet Biotherapeutics Holdings)?
Which analyst is the currently most reserved on SONN (Sonnet Biotherapeutics Holdings)?
